FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects

NCT05905913 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ANT3310
DRUG: ANT3310-placebo
DRUG: ANT3310
DRUG: ANT3310-placebo
DRUG: ANT3310-placebo
DRUG: ANT3310
DRUG: Meropenem
DRUG: Meropenem-placebo

Sponsor

Antabio